1-8 of 8
Jean Pierre Vilque, MD
Close
Sort by
Journal Articles

Bendamustine-Based (BeEAM) Conditioning before Autologous Stem Cell Transplantation: Result of a French Multicenter Study of 386 Patients from Lysa Centers

Sylvain Chantepie, MD, Emmanuelle Tchernonog, MD, Frederic Peyrade, MD, Marie-Virginie Larcher, MD, Momar Diouf, MD, Luc Mathieu Fornecker, MD PhD, Roch Houot, MD PhD, Thomas Gastinne, MD, Carole Soussain, MD PhD, Sandra Malak, MD, Olivier Tournilhac, MD PhD, Caroline Delette, Ahmad Ibrahim, Anne-Claire Gac, MD, Jean-Pierre Vilque, MD, Mohamed Amine Bekadja, Rene-Olivier Casasnovas, MD, Remy Gressin, MD, Arnaud Jaccard, MD PhD, Benjamin Carpentier, Reda Garidi, MD, Bachra Choufi, MD, Stéphanie Guidez, MD, Adrian Tempescul, MD, Adrien Chauchet, MD, Emmanuel Gyan, MD PhD, Ibrahim Yakoub-Agha, MD PhD, Krimo Bouabdallah, MD, Eric Durot, MD, Gandhi Damaj, MD
Journal: Blood
Blood (2016) 128 (22): 3450.
https://doi.org/10.1182/blood.V128.22.3450.3450
Published: 2016
Journal Articles

Frontline Therapy with the Ribvd Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final Results of a Prospective Phase II Trial By the Lysa Group

Remy Gressin, MD, Mary Callanan, MD PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Marie Pierre Moles, MD, Guillaume Cartron, MD, Roch Houot, MD PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD PhD, Anne Banos, MD, Christiane Mounier, MD, Jehan Dupuis, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD PhD, Lionel Karlin, Pierre Feugier, MD PhD, Luc Matthieu Fornecker, MD, Cecile Chabrot, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Katell Le Dû, Nadine Morineau, Hacene Zerazhi, MD, Jean Fontan, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MDPhD, Steven Le Gouill, MD PhD, Ghandi Damaj, MD
Journal: Blood
Blood (2014) 124 (21): 148.
https://doi.org/10.1182/blood.V124.21.148.148
Published: 2014
Journal Articles

Bendamustine, Bortezomib and Dexamethasone (BVD) In Elderly Patients With Multiple Myeloma In First Relapse: Final Analysis Of The Intergroupe Francophone Du Myelome (IFM) 2009-01 Trial

Philippe Rodon, MD, Cyrille Hulin, MD, Brigitte Pegourie, MD, Mourad Tiab, MD, Bruno Anglaret, MD, Lotfi Benboubker, MD, Henry Jardel, Olivier Decaux, MD, Brigitte Kolb, MD, Murielle Roussel, MD, Laurent Garderet, MD, Xavier Leleu, MD, PhD, Olivier Fitoussi, MD, Carine Chaleteix, MD, Philippe Casassus, MD, Pascal Lenain, MD, Bruno Royer, MD, Anne Banos, MD, Riad Benramdane, Pascale Cony-Makhoul, MD, Mamoun Dib, Jean Fontan, Anne-Marie Stoppa, MD, Catherine Traulle, MD, Jean-Pierre Vilque, MD, Marie-Odile Petillon, Claire Mathiot, MD, Hervé Avet-Loiseau, MD, PhD, Philippe Moreau, MD
Journal: Blood
Blood (2013) 122 (21): 1971.
https://doi.org/10.1182/blood.V122.21.1971.1971
Published: 2013
Journal Articles

The Ribvd Regimen (Rituximab IV, Bendamustine IV, Velcade SC, Dexamethasone IV) Offers a High Complete Response Rate In Elderly Patients With Untreated Mantle Cell Lymphoma. Preliminary Results Of The Lysa Trial “Lymphome Du Manteau 2010 SA”

Remy Gressin, MD, Mary Callanan, MD, PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Guillaume Cartron, MD, PhD, Anne Schmitt, MD, Roch Houot, MD, PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD, PhD, Anne Banos, MD, Jehan Dupuis, MD, Christiane Mounier, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD, PhD, Lionel Kardin, MD, Gandhi Damaj, MD, Pierre Feugier, MD, PhD, luc Matthieu Fornacker, MD, Cecile molucon Chabrot, MD, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Philippe Solal-Céligny, MD, Nadine Morineau, MD, Marie Pierre Moles, MD, Hacene Zerazhi, MD, Jean Fontan, MD, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MD PhD, Steven Le Gouill, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 370.
https://doi.org/10.1182/blood.V122.21.370.370
Published: 2013
Journal Articles

Safety and Efficacy of Abbreviated Induction with Oral Fludarabine (F) and Cyclophosphamide (C) Combined with Dose-Dense IV Rituximab (R) in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL) Aged > 65 years : Results of a Multicenter Trial (LLC 2007 SA) On Behalf of the French Goelams/Fcgcll-WM Intergroup

Caroline Dartigeas, MD, Eric Van Den Neste, MD, PhD, Christian Berthou, MD, Herve Maisonneuve, MD, Stéphane Leprêtre, MD, Marie-Sarah Dilhuydy, MD, Marie-Christine Bene, MD, PhD, Florence Nguyen-Khac, MD, PhD, Remi Letestu, MD, Florence Cymbalista, MD, PhD, Sophie De Guibert, MD, Thérèse Aurran, MD, Kamel Laribi, MD, Jean Pierre Vilque, MD, Olivier Tournilhac, MD, PhD, Alain Delmer, MD, Pierre Feugier, MD, PhD, Bruno Cazin, MD, Anne-Sophie Michallet, MD, PhD, Vincent Levy, MD, PhD, Xavier Troussard, MD, Roselyne Delepine, Bruno Giraudeau, PhD, Philippe Colombat, MD, Véronique Leblond, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 434.
https://doi.org/10.1182/blood.V120.21.434.434
Published: 2012
Journal Articles

TP53 Mutation Profile and New Mutations in Chronic Lymphocytic Leukemia in Normandy

Nordine Lahyane, Julien Alani, Xavier Troussard, MD, PhD, Stephane Cheze, MD, Jean-Pierre Vilque, MD, Seyeffedine Kadi, MD, Vincent Launay, MD, Edouard Cornet, MD, Dina Istasi, MBBCH, MD, CES
Journal: Blood
Blood (2011) 118 (21): 4593.
https://doi.org/10.1182/blood.V118.21.4593.4593
Published: 2011
Journal Articles

GMCLI, Goelams Mantle Cell Lymphoma Index, a New Prognostic Index of Survival for MCL Patients Treated with VAD-C and Autologous PBSCT.

Remy Gressin, MD, Sylvie Caulet Maugendre, MD, Eric Deconinck, MD, Olivier Tournilhac, MD, Martine Dartigeas, MD, Marie Pierre Moles, MD, Gerard Lepeu, MD, Denis Guyotat, MD, Eric Legouffe, MD, Jacqueline Dugay, MD, Claude Martin, MD, Philippe Casassus, MD, Jean Pierre, Vilque, MD, Christiane Ghandour, MD, Isabelle Grulois, MD, Frederic Maloisel, MD, Christine Le Maignan, MD, Jean Pierre De Jaureguiberry, MD, Antoine Thyss, MD, Virginie Lucas, MD, Sylvie Cailleres, MD, Philippe Rodon, MD, Jean Luc Dutel, MD, Philippe Colombat, MD, Emmanuel Gyan, MD
Journal: Blood
Blood (2006) 108 (11): 2447.
https://doi.org/10.1182/blood.V108.11.2447.2447
Published: 2006
Journal Articles

The VIP-ABVD Regimen Is Not Superior to the CHOP 21 for the Treatment of Non Epidermotropic Peripheral T Cell Lymphoma. Final Results of the “LTP95” Protocol of the GOELAMS.

Remy Gressin, MD, Michel Peoch, MD, Eric Deconinck, MD, Philippe Casassus, MD, Bernard Desablens, MD, Delphine Senecal, MD, Philippe Quitet, MD, Jean Pierre Vilque, MD, Charles Foussard, MD, Houchingue Eghbali, MD, Jerome Jaubert, MD, Olivier Tournilhac, MD, Virginie Lucas, MD, Vincent Delwail, MD, Bachera Choufi, MD, Antoine Thyss, MD, Francoise Huguet, MD, Frederic Maloisel, MD, Bruno Richard, MD, Noel-Jean Milpied, MD, Philippe Colombat, MD
Journal: Blood
Blood (2006) 108 (11): 2464.
https://doi.org/10.1182/blood.V108.11.2464.2464
Published: 2006